Insulet Corp

PODD: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
N@%LOCK|>^MR%LOCK|L@kqYZ$

Insulet Earnings: Stellar Finish to 2025 With Strong Fourth Quarter

Insulet delivered fourth-quarter revenue growth of 29% in constant currency, fueled by 42% growth outside the US. Quarterly operating margin also expanded by 40 basis points. Shares rose by about 8% in early trading.

Sponsor Center